A big issue involving medical marijuana has emerged in the past year: Many people prefer using marijuana for their condition rather than opioids.

Former NFL and NBA players have come forward to say that both leagues should allow players to at least try marijuana for pain management, given the known issues with opioid use and the ongoing overdose epidemic.

Numerous studies are underway around the world to learn of the potential health benefits of using marijuana, including for pain management.

However, it wasn’t until recently that someone put data together to find out just what a massive switch to naturally grown marijuana and away from prescription drugs could do to the pharmaceutical industry.

Billions and Billions Lost

New Frontier Data, a Washington, D.C.-based data analytics company that focuses on the legal marijuana industry, recently researched what would happen if people used marijuana rather than prescription drugs for the nine illnesses most commonly treated by marijuana.

They found that Big Pharma could lose almost $5 billion a year. The catch: The company’s analysis is based on the concept that marijuana will become legal across the nation.

While that seems highly unlikely under the current White House and Congress, it still shows how much is at stake financially with medical marijuana. The question is not just what legal marijuana companies could earn, but what sales Big Pharma could lose.

The Nine Conditions

New Frontier Data considered only the medical conditions that physicians most often prescribe medical marijuana to treat, in states where medical marijuana is legal.

They are:

Chronic pain

Post-traumatic stress disorder

Sleep disorders

Anxiety

Nerve pain

Chemotherapy-induced nausea

Tourette syndrome

Glaucoma

Seizures/epilepsy

They then considered a 2016 study by researchers at the University of Georgia who found, among other things, that the amount of prescriptions for drugs dropped by 11 percent among older patients in states where medical marijuana is legal.

Based on that percentage figure, New Frontier than gathered data on how much is spent across the country on prescriptions drugs for the above nine conditions. Their analysis shows that medical marijuana could take away about $4.4 billion to $4.9 billion a year from pharmaceutical sales.

Chances of Nationwide Legalization

The Trump Administration stance on legalized recreational marijuana has been well-documented. However, other than comments by Attorney General Jeff Sessions, the stance on medical marijuana seems much more tolerant than that for recreational, or adult-use, marijuana.

However, a new wrinkle has developed. The same father/daughter University of Georgia research team – Ashley Bradford and W. David Bradford – have released a new study that shows the preference for marijuana is significant across all age demographics.

The previous study that showed the 11 percent drop focused primarily on older Americans on Medicaid. The more recent study looked a patients of all ages and found that the same preference for marijuana over prescription drugs was prevalent among many.

For instance, there was a 17 percent reduction in prescriptions filled for nausea in states where marijuana is legal, as well as 13 percent drop in prescriptions for those with depression.

Follow dispensaries.com on Twitter to stay up to date on the latest cannabis news.

From retailers to growers, producers, and suppliers, there’s a seemingly never-ending list of startup opportunities in this emerging market. In Start Your Own Cannabis Business, marijuana, biotech, and entrepreneurship reporter Javier Hasse introduces forward-thinking entrepreneurs like you to the industry and shares hard-earned tips and success stories from pioneers and visionaries in the marijuana industry.

The information contained on this website ("Content") represents the views and opinions of the persons or entities expressing them. The Content does not represent an endorsement by, or the views and opinions of, Entrepreneur Media, Inc. ("EMI"), is intended for informational and educational purposes only, and should in no way be interpreted as medical, legal, or any other advice concerning the cultivation, sale, or any other use of marijuana, which, although legal in some states and local jurisdictions throughout the United States, is currently illegal under federal law, as well as in other states and local jurisdictions. Because of the variety of laws, regulations, and ordinances concerning marijuana, the Content may not be suitable for your situation. Consequently, EMI makes no expressed or implied warranties nor assumes any liability whatsoever, concerning the accuracy or reliability of the information contained herein, including warranties about the legality of, or likelihood of success in, conducting a cannabis business. EMI does not advocate violating applicable law, and therefore strongly recommends that you carefully research applicable laws, and consult with appropriate licensed professionals and other experts, before taking any action in connection with, or based on, such Content.

Entrepreneur Media, Inc. values your privacy. In order to understand how people use our site generally, and to create more valuable experiences for you, we may collect data about your use of this site (both directly and through our partners). The table below describes in more detail the data being collected. By giving your consent below, you are agreeing to the use of that data. For more information on our data policies, please visit our Cookie Policy.

Name

Category

Google

Ad Serving, Ad Targeting, Analytics/Measurement, Optimisation

Rubicon

Ad Serving

Teads

Ad Serving

Nativo

Ad Serving

Teads

Ad Serving

New Relic

Analytics/Measurement

Log Entries

Analytics/Measurement

Sailthru

Content Customization

I confirm that I am over the age of 16 and consent to the collection of the above data.